CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Polynovo Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Polynovo Ltd
2/320 Lorimer Street
Phone: +61 800958289p:+61 800958289 MELBOURNE, VIC  3207  Australia Ticker: PNVPNV

Business Summary
PolyNovo Limited is an Australia-based company, which is engaged in the development of medical devices for various medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM product is designed to help surgeons treat traumatic wounds. NovoSorb BTM may be used to temporarily close the wound and aid the body in generating new tissue. It is indicated for full or deep partial-thickness burns, surgical and reconstructive wounds and traumatic wounds. BTM is applied to a wound once the unhealthy or dead tissue has been surgically removed. NovoSorb is a medical-grade polymers that can be expressed in a range of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board David J.Williams 3/13/2014 2/28/2014
Chief Executive Officer SwamiRaote 7/29/2022 7/29/2022
Chief Financial Officer, Company Secretary JanGielen 12/12/2018 12/12/2018
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Calzada Limited
MBP
Metabolic Pharmaceuticals Limited
PNV
PolyNovo Biomaterials Pty Ltd

General Information
Number of Employees: 237 (As of 12/31/2023)
Outstanding Shares: 690,232,751 (As of 12/31/2023)
Shareholders: 19,999
Stock Exchange: ASX
Fax Number: +61 386814099


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024